Literature DB >> 6316187

Neurotoxicity of vincristine after the osmotic opening of the blood-brain barrier.

K Tomiwa, F Hazama, H Mikawa.   

Abstract

The direct effect of intravascularly injected vincristine on the rat brain was investigated after the osmotic opening of the blood-brain barrier. This was opened unilaterally by injecting 2.5 ml of 1.4 molal mannitol solution into the right carotid artery through a cannula inserted in the external carotid artery in retrograde fashion. Vincristine (0.75 mg/kg) was then injected into either the carotid artery or into a vein. Animals, thus treated, developed left hemiparesis and choreo-athetoid head motion within several days. Microscopical analysis revealed 1 intracytoplasmic eosinophilic inclusions at an early period, 2 neuronal argyrophilic change and axonal thickening with spheroid formation at later times, and 3 glial mitotic arrest, a finding not reported in the previous studies with intrathecal injection of vincristine. Neuronal changes were usually confined to the selected area in the midbrain, whereas glial mitotic figures were seen in the hippocampus, midbrain and cerebellum. These changes are thought to be direct effects of the vincristine binding with cellular microtubules, including mitotic spindle tubules and neurotubules. The transient opening of the blood-brain barrier seems to be a useful technique for studying the experimental neurotoxicology of drugs to which the blood-brain barrier is impermeable.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6316187     DOI: 10.1111/j.1365-2990.1983.tb00120.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  7 in total

Review 1.  Osmotic opening of the blood-brain barrier: principles, mechanism, and therapeutic applications.

Authors:  S I Rapoport
Journal:  Cell Mol Neurobiol       Date:  2000-04       Impact factor: 5.046

Review 2.  Blood-brain barrier and new approaches to brain drug delivery.

Authors:  W M Pardridge; R J Boado; K L Black; P A Cancilla
Journal:  West J Med       Date:  1992-03

3.  Mind the Gaps: Ontogeny of Human Brain P-gp and Its Impact on Drug Toxicity.

Authors:  Jean-Marie Nicolas; Elizabeth C M de Lange
Journal:  AAPS J       Date:  2019-05-28       Impact factor: 4.009

4.  Syndrome of inappropriate secretion of antidiuretic hormone caused by vincristine therapy: a case report of the neuropathology.

Authors:  K Tomiwa; H Mikawa; F Hazama; K Yazawa; R Hosoya; T Ohya; K Nishimura
Journal:  J Neurol       Date:  1983       Impact factor: 4.849

5.  Chemotherapy in experimental brain tumor, part 2: pretreatment with leukotriene C4 prolongs survival.

Authors:  P Black; C M Hand; J R Vender; S D Finkelstein
Journal:  J Neurooncol       Date:  1998-01       Impact factor: 4.130

6.  Brain uptake and anticancer activities of vincristine and vinblastine are restricted by their low cerebrovascular permeability and binding to plasma constituents in rat.

Authors:  N H Greig; T T Soncrant; H U Shetty; S Momma; Q R Smith; S I Rapoport
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

7.  Leukotriene E4 selectively increase the delivery of methotrexate to the C6 gliomas in rats.

Authors:  C C Chio; S J Lin; M T Lin
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.